LOSURDO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 8.003
AS - Asia 2.881
EU - Europa 2.389
SA - Sud America 694
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 14.095
Nazione #
US - Stati Uniti d'America 7.861
SG - Singapore 1.159
IT - Italia 787
CN - Cina 574
BR - Brasile 556
RU - Federazione Russa 375
HK - Hong Kong 371
SE - Svezia 332
DE - Germania 246
VN - Vietnam 238
FR - Francia 150
GB - Regno Unito 140
FI - Finlandia 102
IN - India 96
BD - Bangladesh 85
CA - Canada 69
IQ - Iraq 55
ID - Indonesia 54
BE - Belgio 51
AR - Argentina 46
TR - Turchia 42
MX - Messico 41
NL - Olanda 34
PL - Polonia 33
ZA - Sudafrica 32
PK - Pakistan 31
CO - Colombia 30
ES - Italia 29
UA - Ucraina 26
UZ - Uzbekistan 22
EC - Ecuador 20
JP - Giappone 20
SA - Arabia Saudita 20
IE - Irlanda 14
MA - Marocco 14
EG - Egitto 13
PH - Filippine 13
VE - Venezuela 12
AT - Austria 11
CI - Costa d'Avorio 11
DZ - Algeria 11
MY - Malesia 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
JO - Giordania 9
TN - Tunisia 9
AL - Albania 7
CL - Cile 7
GR - Grecia 7
KE - Kenya 7
KZ - Kazakistan 7
AU - Australia 6
CH - Svizzera 6
IL - Israele 6
JM - Giamaica 6
KR - Corea 6
LB - Libano 6
NP - Nepal 6
RO - Romania 6
BO - Bolivia 5
EU - Europa 5
LT - Lituania 5
PY - Paraguay 5
TH - Thailandia 5
BG - Bulgaria 4
HN - Honduras 4
MK - Macedonia 4
PA - Panama 4
PS - Palestinian Territory 4
QA - Qatar 4
BB - Barbados 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GA - Gabon 3
GT - Guatemala 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
IR - Iran 2
KW - Kuwait 2
MD - Moldavia 2
PR - Porto Rico 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZW - Zimbabwe 2
AM - Armenia 1
BJ - Benin 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 14.078
Città #
Fairfield 869
Ashburn 839
Woodbridge 626
Singapore 613
Chandler 449
San Jose 394
Houston 380
Hong Kong 368
Seattle 341
Wilmington 299
Milan 297
Cambridge 293
Ann Arbor 286
Nyköping 278
Beijing 209
New York 171
Dallas 152
Council Bluffs 109
Los Angeles 99
Rome 91
Lawrence 88
Jacksonville 87
Roxbury 85
Lauterbourg 78
Ho Chi Minh City 71
Nanjing 67
Munich 60
Santa Clara 56
Bari 54
Helsinki 54
Inglewood 54
Des Moines 53
Brussels 51
Columbus 51
São Paulo 49
Hanoi 45
Brooklyn 41
Atlanta 40
Boardman 39
Princeton 39
Buffalo 35
Jakarta 35
Frankfurt am Main 32
San Diego 32
Dearborn 31
Chicago 29
Turin 27
Warsaw 27
Orem 26
Montreal 24
Falkenstein 23
Denver 22
Nuremberg 21
London 20
Dong Ket 19
Figino 19
Rio de Janeiro 19
Baghdad 18
Bologna 18
Dhaka 18
Hebei 18
Mexico City 18
Paris 18
San Francisco 18
Tashkent 18
Tokyo 18
Belo Horizonte 17
Johannesburg 17
Stockholm 17
The Dalles 17
Nanchang 16
Haiphong 15
Phoenix 15
Toronto 15
Chennai 14
Jiaxing 14
Tianjin 14
Brasília 13
Dublin 13
Istanbul 13
Medellín 13
Shenyang 13
Pune 12
Abidjan 11
Boston 11
Curitiba 11
Da Nang 11
Lahore 11
Cairo 10
Amsterdam 9
Poplar 9
Redwood City 9
Amman 8
Ankara 8
Baku 8
Buenos Aires 8
Guangzhou 8
Hangzhou 8
Hefei 8
Maringá 8
Totale 9.332
Nome #
Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study 536
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 268
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 210
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 209
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 206
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 196
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 196
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 190
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 188
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 186
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 174
Curcumin and colorectal cancer: From basic to clinical evidences 171
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 165
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 161
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 154
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 146
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 145
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 143
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 142
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 142
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 137
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 134
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 133
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 131
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 127
Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study 126
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 126
An uncommon etiology of pancreatitis after endoscopic ultrasound-guided fine needle aspiration 123
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 122
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients 120
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 118
Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis 114
Seronegative celiac disease: where is the specific setting? 111
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 111
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 111
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 110
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 110
Checkpoint Inhibitor-Induced Colitis: An Update 108
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 106
The influence of small intestinal bacterial overgrowth in digestive and extra-intestinal disorders 106
Assessment of body composition: Intrinsic methodological limitations and statistical pitfalls 106
Endoscopic stenting for colorectal cancer obstruction as a bridge-to-surgery strategy 105
Human leukocyte antigen (Hla) haplotype does not influence the inflammatory pattern of duodenal lymphocytosis linked to irritable bowel syndrome 104
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 101
null 101
null 100
Might helicobacter pylori play a role in allergic or cross-reaction related disorders? 100
Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial 99
null 99
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 97
null 94
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 94
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 94
Liver involvement in inflammatory bowel disease: What should the clinician know? 93
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? 91
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase 91
Estrogen receptors in colorectal cancer: Facts, novelties and perspectives 89
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 87
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 86
null 86
null 86
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 86
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity—authors’ reply 86
null 85
Letter: Portal vein obstruction - Which subset of patients could benefit the most? 85
Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis 84
Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy 83
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 83
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 83
null 82
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) 81
null 81
null 81
Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages 81
null 80
Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation 80
Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation—Authors’ reply 80
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 79
Familial intestinal polyposis and device assisted enteroscopy: where do we stand? 79
null 79
null 79
Fibres and Colorectal Cancer: Clinical and Molecular Evidence 76
Effect of metronidazole resistance on Helicobacter pylori eradication regimens 75
Helicobacter pylori Secondary Antibiotic Resistance after One or More Eradication Failure: A Genotypic Stool Analysis Study 75
null 74
Sequential therapy for helicobacter pylori in elderly patients: Effectiveness, safety and predictors of success 74
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association 74
Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties 73
null 73
null 73
Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept 73
Effect of Visual Booklets to Improve Bowel Preparation in Colonoscopy: Systematic Review with Meta-Analysis 72
null 72
null 72
The State of the Art of Molecular Fecal Investigations for Helicobacter pylori (H. pylori) Antibiotic Resistances 72
Second-line Therapy for Helicobacter Pylori Eradication: State of the Art 71
null 71
null 71
null 70
null 70
Totale 11.333
Categoria #
all - tutte 57.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.848


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022670 66 10 14 17 45 70 20 32 52 62 115 167
2022/20231.115 148 187 85 74 90 169 21 134 152 5 32 18
2023/2024416 29 69 16 47 26 137 6 7 2 34 8 35
2024/20252.039 56 25 106 32 38 183 297 210 93 136 285 578
2025/20265.419 724 242 332 470 641 215 484 149 785 576 209 592
2026/2027718 718 0 0 0 0 0 0 0 0 0 0 0
Totale 14.688